MSC Exosomes for Osteoarthritis
Osteoarthritis (OA) is one of the most actively studied areas for MSC-derived exosomes in regenerative research. This overview is for research and educational purposes only.
What MSC exosomes are
MSC-derived exosomes are cell-free extracellular vesicles (roughly 30–150 nm) carrying signaling cargo such as proteins, lipids, and microRNA. They are supplied by BioRegenEx as characterized, research-use-only material with per-lot documentation.
What the research explores
In preclinical OA models, MSC-derived exosomes have been studied for signaling related to chondrocyte biology, cartilage matrix, and joint inflammation. These are research findings only. Explore the studies in our Exosome Research Library under Osteoarthritis and Orthopedic & Cartilage.
Key Published Research
Human clinical evidence listed first, then preclinical. Every entry links to its PubMed record.
- Injection of human umbilical cord mesenchymal stem cell exosomes for the treatment of knee osteoarthritis: from preclinical to clinical research. J Transl Med, 2025. HUMAN randomized controlled trial. (PubMed)
- Anti-inflammatory and immunomodulatory effects of extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis. J Nanobiotechnology, 2022. Preclinical. (PubMed)
- The potential use of mesenchymal stem cells and their derived exosomes for orthopedic diseases treatment. Stem Cell Rev Rep, 2022. Review. (PubMed)
- Safety and efficacy of placental mesenchymal stromal cell-derived extracellular vesicles in knee osteoarthritis. BMC Musculoskelet Disord, 2024. HUMAN clinical trial. (PubMed)
- Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stem cells for osteoarthritis. J Nanobiotechnology, 2025. Preclinical. (PubMed)
- Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis. Stem Cell Res Ther, 2022. Review. (PubMed)
- Harnessing tissue-derived extracellular vesicles for osteoarthritis theranostics. Theranostics, 2022. Review. (PubMed)
Sourcing considerations
For research use, look for characterized lots (particle size and concentration), sterility and endotoxin screening, cold-chain handling, and clear research-use-only labeling. Read our orthopedic sourcing guide.
Frequently Asked Questions
Are MSC exosomes an approved osteoarthritis treatment?
No. They are not FDA-approved to treat OA or any condition and are supplied for research use only (RUO).
How are exosomes studied for joints?
Preclinical research examines signaling involved in cartilage and joint biology, often in intra-articular models.
For research and educational purposes; research-use-only.
These statements have not been evaluated by the FDA. BioRegenEx supplies MSC-derived exosomes for research use only (RUO); they are not intended to diagnose, treat, cure, or prevent any disease. This content is educational and is not medical advice.